RCM
MLAB icon

Raleigh Capital Management’s Mesa Laboratories MLAB Stock Holding History

Raleigh Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-81
Closed -$8.49K – 1102
2023
Q4 		$8.49K Buy
+81
New +$7.89K ﹤0.01% 628

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Raleigh Capital Management's MLAB Position: Q1 2024 in Review

Raleigh Capital Management sold out of Mesa Laboratories (MLAB) in Q1 2024, closing a stake of 81 shares — an estimated $8.49K sold.

Raleigh Capital Management first reported a position in MLAB in Q4 2023 and held it in 1 quarter. The position peaked at $8.49K in Q4 2023. 155 funds tracked by Wall St. Rank hold MLAB as of Q1 2024.

  • Raleigh Capital Management reported no remaining Mesa Laboratories position as of Q1 2024 after selling out during the quarter.
  • Raleigh Capital Management sold 81 Mesa Laboratories shares in Q1 2024, an estimated $8.49K.
  • Raleigh Capital Management first reported a position in Mesa Laboratories in Q4 2023 and held it in 1 quarter.
  • Raleigh Capital Management's Mesa Laboratories position peaked at $8.49K in Q4 2023.
  • 155 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2024.

Based on Raleigh Capital Management's 13F filing for Q1 2024, filed 13 May 2024.